Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (1)
  • MEK
    (1)
Filter
Search Result
Results for "

T5857

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    1
    TargetMol | All_Pathways
Trametinib (DMSO solvate)
Trametinib DMSO solvate, Trametinib dimethyl sulfoxide, JTP-74057 (DMSO solvate), GSK-1120212 (DMSO solvate)
T58571187431-43-1
Trametinib (DMSO solvate) (GSK-1120212 (DMSO solvate)) is a highly potent and selective MEK inhibitor that specifically inhibits MEK1/2 (IC50: 2 nM).
  • $41
In Stock
Size
QTY
TargetMol | Citations Cited
Trametinib-13C6
TMID-0691
Trametinib-13C6 is a 13C labeled version of Trametinib. Trametinib (GSK1120212; JTP-74057) is an orally active MEK inhibitor with IC50 values of 2 nM for MEK1 and MEK2. It has the capability to activate autophagy and induce apoptosis.
  • Inquiry Price
Inquiry
Size
QTY
Trametinib
JTP-74057, GSK1120212
T2125871700-17-3
Trametinib (GSK1120212) is a MEK inhibitor that inhibits MEK1 and MEK2 (IC50=0.7/0.9 nM) with ATP non-competitive and oral activity. Trametinib activates autophagy and induces apoptosis.
  • $31
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Trametinib-d4
TMID-0655
Trametinib-d4 is the deuterated form of Trametinib. Trametinib (GSK1120212; JTP-74057) is an orally bioavailable MEK inhibitor, effectively inhibiting MEK1 and MEK2 with an IC50 of 2 nM. Additionally, Trametinib can activate autophagy and induce apoptosis.
  • Inquiry Price
Inquiry
Size
QTY